Victoria Alexandrovna Kuryaninova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Victoria Alexandrovna Kuryaninova has a total of 190 co-authors. Here are the top co-authors by number of shared publications:
- Leonid Yakovlevich Klimov
Stavropol State Medical University
28 shared publications - Irina N. Zakharova
Russian Medical Academy of Continuous Professional Education
18 shared publications - Svetlana V. Dolbnya
Stavropol State Medical University; Regional Children’s Clinical Hospital
16 shared publications - Marina V. Stoyan
Stavropol State Medical University
8 shared publications - Anastasia V. Yagupova
Stavropol State Medical University
7 shared publications - Anna N. Tsutsaeva
Stavropol State Medical University
7 shared publications
Latest Publications
- Open Access
- 22 January 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 17-31
Social and psychological portrait of a child with celiatic disease and his family: results of a pilot study
Introduction. The history of celiac disease research spans more than one millennium, but it is only in the middle of the 20th century that the causal role of gluten was proved. Moreover, the 75 years since then were marked by impressive achievements that enabled an understanding of the nuances of pathogenesis, the development of highly informative diagnostic methods, and the identification of trends in drug treatments for gluten-associated diseases. Given that gluten intolerance and the resulting group of pathological conditions are widespread in the human population as a whole, studies of the quality of life, socio-economic and psychological aspects of the patients’ lives and their immediate environment are of particular value. Purpose of the study. To examine whether children with celiac disease and their immediate environment are satisfied with the availability and quality of social support measures. Materials and methods. This study was based on the results of an online survey conducted among 179 respondents (children, parents and guardians) with an established diagnosis of celiac disease using an original questionnaire to study the satisfaction of celiac patients with the availability and quality of social support measures. Results and discussion. The results of the study suggest that celiac disease in children has a multidimensional impact on the family’s daily life, going beyond clinical issues and affecting a wide range of social, organizational and psychological aspects, representing not only a medical problem, but also a persistent source of social difficulties, which necessitates comprehensive interdisciplinary support. The identified difficulties in confirming the diagnosis and organizing medical support allow us to hypothesize about insufficient integration of patients with celiac disease into primary health care and the lack of medical awareness. That is, children with celiac disease and their families remain in conditions of latent social and medical instability, without receiving a full-fledged, multidisciplinary trajectory of support. At the same time, fragmentary knowledge about social support measures indicates a deficit of institutional information and opacity of mechanisms for inclusion in the care system. This allows us to conclude that celiac disease does not yet hold an important place in the social policy system and remains insufficiently taken into account when forming specialized support measures, and that there is no systemic approach to supporting this group. In addition, the survey results record a persistent impact of the disease on daily activity, including limited mobility, difficulties with organizing meals outside the home, and challenges in academic inclusion. At the same time, against the background of the relatively preserved interpersonal communications and the significant role of support from family members, we can assume the presence of compensatory mechanisms grounded in the resource potential of the immediate social environment. That is, the sustainability of families with a child suffering from celiac disease relies rather on informal resources and internal strategies than on systemic external support. Conclusion. Celiac disease in children is not only a medical problem, but also an indicator of institutional vulnerability, structural gaps in routing, support and information. Effective integration of families into the support system requires a comprehensive interdepartmental model, including: regulatory consolidation of support measures, regular updating and dissemination of information in an accessible form, expansion of gastroenterological services and development of infrastructure for a safe everyday life.
- 22 January 2026
- Published by LLC Global Media Technology in Experimental and Clinical Gastroenterology
- No. 6,p. 17-31
Open AccessSocial and psychological portrait of a child with celiatic disease and his family: results of a pilot study
Introduction. The history of celiac disease research spans more than one millennium, but it is only in the middle of the 20th century that the causal role of gluten was proved. Moreover, the 75 years since then were marked by impressive achievements that enabled an understanding of the nuances of pathogenesis, the development of highly informative diagnostic methods, and the identification of trends in drug treatments for gluten-associated diseases. Given that gluten intolerance and the resulting group of pathological conditions are widespread in the human population as a whole, studies of the quality of life, socio-economic and psychological aspects of the patients’ lives and their immediate environment are of particular value. Purpose of the study. To examine whether children with celiac disease and their immediate environment are satisfied with the availability and quality of social support measures. Materials and methods. This study was based on the results of an online survey conducted among 179 respondents (children, parents and guardians) with an established diagnosis of celiac disease using an original questionnaire to study the satisfaction of celiac patients with the availability and quality of social support measures. Results and discussion. The results of the study suggest that celiac disease in children has a multidimensional impact on the family’s daily life, going beyond clinical issues and affecting a wide range of social, organizational and psychological aspects, representing not only a medical problem, but also a persistent source of social difficulties, which necessitates comprehensive interdisciplinary support. The identified difficulties in confirming the diagnosis and organizing medical support allow us to hypothesize about insufficient integration of patients with celiac disease into primary health care and the lack of medical awareness. That is, children with celiac disease and their families remain in conditions of latent social and medical instability, without receiving a full-fledged, multidisciplinary trajectory of support. At the same time, fragmentary knowledge about social support measures indicates a deficit of institutional information and opacity of mechanisms for inclusion in the care system. This allows us to conclude that celiac disease does not yet hold an important place in the social policy system and remains insufficiently taken into account when forming specialized support measures, and that there is no systemic approach to supporting this group. In addition, the survey results record a persistent impact of the disease on daily activity, including limited mobility, difficulties with organizing meals outside the home, and challenges in academic inclusion. At the same time, against the background of the relatively preserved interpersonal communications and the significant role of support from family members, we can assume the presence of compensatory mechanisms grounded in the resource potential of the immediate social environment. That is, the sustainability of families with a child suffering from celiac disease relies rather on informal resources and internal strategies than on systemic external support. Conclusion. Celiac disease in children is not only a medical problem, but also an indicator of institutional vulnerability, structural gaps in routing, support and information. Effective integration of families into the support system requires a comprehensive interdepartmental model, including: regulatory consolidation of support measures, regular updating and dissemination of information in an accessible form, expansion of gastroenterological services and development of infrastructure for a safe everyday life.
- Open Access
- 6 October 2025
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 22 (4) , 495-522
“Celiac Disease-2025”: Project of Clinical Guidelines for the Diagnosis and Treatment of Celiac Disease in Children
The authors present current data on the etiology, pathogenesis, clinical manifestations of celiac disease in children of different ages, associated diseases, laboratory and instrumental diagnostics, diet therapy, additional treatment methods, vaccination, and follow-up of children with celiac disease based on the developed clinical guidelines “Celiac Disease. Children”.
- 6 October 2025
- Published by Paediatrician Publishers LLC in Pediatric pharmacology
- Vol. 22 (4) , 495-522
Open Access“Celiac Disease-2025”: Project of Clinical Guidelines for the Diagnosis and Treatment of Celiac Disease in Children
The authors present current data on the etiology, pathogenesis, clinical manifestations of celiac disease in children of different ages, associated diseases, laboratory and instrumental diagnostics, diet therapy, additional treatment methods, vaccination, and follow-up of children with celiac disease based on the developed clinical guidelines “Celiac Disease. Children”.
- Open Access
- 11 July 2025
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 24 (3) , 157-161
Quality of Life of Patients with Celiac Disease on Gluten-Free Diet: Narrative Review
Nowadays the only effective method of celiac disease management and preventing its complications is strict lifelong gluten-free diet. Compliance to it can be considerably difficult. This review provides the analysis of updated data on the quality of life (QoL) of patients with celiac disease on gluten-free diet. Significant impact of extraintestinal symptoms on QoL occurring during nutritional treatment was noted. However, the use of QoL assessment to determine the nutritional treatment efficacy in children with celiac disease has not been sufficiently studied. The need for psychological correction and social adaptation of patients with celiac disease is discussed.
- 11 July 2025
- Published by Paediatrician Publishers LLC in Current Pediatrics
- Vol. 24 (3) , 157-161
Open AccessQuality of Life of Patients with Celiac Disease on Gluten-Free Diet: Narrative Review
Nowadays the only effective method of celiac disease management and preventing its complications is strict lifelong gluten-free diet. Compliance to it can be considerably difficult. This review provides the analysis of updated data on the quality of life (QoL) of patients with celiac disease on gluten-free diet. Significant impact of extraintestinal symptoms on QoL occurring during nutritional treatment was noted. However, the use of QoL assessment to determine the nutritional treatment efficacy in children with celiac disease has not been sufficiently studied. The need for psychological correction and social adaptation of patients with celiac disease is discussed.
- 25 October 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (5)
Lysosomal acid lipase deficiency and its clinical pathophysiology, enzyme replacement therapy features: bibliographical review and a case report
Lysosomal acid lipase deficiency (LALD) is a rare disease of lysosomal storage inherited in an autosomal recessive manner and caused by damaging mutations in the LIPA gene encoding the synthesis of the enzyme lysosomal acid lipase (LAL). Authors represent basic information about LALD, describe its typical clinical and laboratory manifestations, features of enzyme replacement therapy with Sebelipase alfa (sold under the brand name KANUMA®), which is a recombinant form of the enzyme LAL, outcomes and prognosis of the disease in children. Modern methods for the LALD detection and an algorithm for diagnosing the disease in patients with hypertransaminasemia are discussed as well. A clinical case report of LALD with proven effectiveness of treatment with Sebelipase alfa (KANUMA®) in a pediatric patient are given.
- 25 October 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (5)
Lysosomal acid lipase deficiency and its clinical pathophysiology, enzyme replacement therapy features: bibliographical review and a case report
Lysosomal acid lipase deficiency (LALD) is a rare disease of lysosomal storage inherited in an autosomal recessive manner and caused by damaging mutations in the LIPA gene encoding the synthesis of the enzyme lysosomal acid lipase (LAL). Authors represent basic information about LALD, describe its typical clinical and laboratory manifestations, features of enzyme replacement therapy with Sebelipase alfa (sold under the brand name KANUMA®), which is a recombinant form of the enzyme LAL, outcomes and prognosis of the disease in children. Modern methods for the LALD detection and an algorithm for diagnosing the disease in patients with hypertransaminasemia are discussed as well. A clinical case report of LALD with proven effectiveness of treatment with Sebelipase alfa (KANUMA®) in a pediatric patient are given.
- 1 January 2024
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS)
Витамин D: от простого к сложному
Монография посвящена актуальной для педиатрии проблеме недостаточности и дефицита витамина D, данная тема рассматривается авторами для совершенстования оказания медицинской помощи детям по профилю «Педиатрия». Монография освещает современные представления о механизмах формирования недостаточности витамина D, профилактических стратегиях у здоровых детей и терапевтических подходах у пациентов с различными заболеваниями. Подробно описана история открытия и изучения витамина D, представлены современные данные о механизмах метаболизма и его генетического контроля. Состояние обеспеченности витамином D рассматривается авторами через призму комплексного анализа эпигенетических факторов, как экзогенных (сезон года), так и эндогенных (возраст, пол, заболевания). Учитывая роль витамина D как фактора, модулирующего процесс воспаления, в монографии проведен анализ обеспеченности им в крупных когортах детей и взрослых различного возраста на территории РФ и за рубежом, в связи с негативными долгосрочными эффектами его низкого содержания. Приведены результаты исследований по уточнению профилактических доз витамина D для практически здоровых, а также детей с хроническими заболеваниями, поскольку без таргетных профилактических стратегий шансы на успех в нормализации уровня витамина D у детей практически минимальны. При подготовке данной монографии обобщены достижения мировой науки, а также собственный клинический опыт всех авторов. Авторский коллектив надеется, что монография будет полезна практикующим врачам различных специальностей, научным сотрудникам, а также студентам медицинских вузов, всем тем, от кого зависит, насколько успешной будет борьба за здоровье и улучшение качества жизни детей.
- 1 January 2024
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS)
Витамин D: от простого к сложному
Монография посвящена актуальной для педиатрии проблеме недостаточности и дефицита витамина D, данная тема рассматривается авторами для совершенстования оказания медицинской помощи детям по профилю «Педиатрия». Монография освещает современные представления о механизмах формирования недостаточности витамина D, профилактических стратегиях у здоровых детей и терапевтических подходах у пациентов с различными заболеваниями. Подробно описана история открытия и изучения витамина D, представлены современные данные о механизмах метаболизма и его генетического контроля. Состояние обеспеченности витамином D рассматривается авторами через призму комплексного анализа эпигенетических факторов, как экзогенных (сезон года), так и эндогенных (возраст, пол, заболевания). Учитывая роль витамина D как фактора, модулирующего процесс воспаления, в монографии проведен анализ обеспеченности им в крупных когортах детей и взрослых различного возраста на территории РФ и за рубежом, в связи с негативными долгосрочными эффектами его низкого содержания. Приведены результаты исследований по уточнению профилактических доз витамина D для практически здоровых, а также детей с хроническими заболеваниями, поскольку без таргетных профилактических стратегий шансы на успех в нормализации уровня витамина D у детей практически минимальны. При подготовке данной монографии обобщены достижения мировой науки, а также собственный клинический опыт всех авторов. Авторский коллектив надеется, что монография будет полезна практикующим врачам различных специальностей, научным сотрудникам, а также студентам медицинских вузов, всем тем, от кого зависит, насколько успешной будет борьба за здоровье и улучшение качества жизни детей.
- Open Access
- 2 December 2023
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 193-197
Vitamin D supplementation in children with urinary tract infection
Urinary tract infections (UTIs) are one of the most common bacterial infections in the global population. Vitamin D deficiency is also an urgent and common problem, and the high incidence of hypovitaminosis does not depend on age, sex, nationality, and geographical location. Along with the so-called "classical" effects of cholecalciferol, no less significant non-calcemic functions of cholecalciferol have been actively studied over the past two decades, particularly its effect on inflammation and its role in anti-infectious immunity. More and more data on the relationship between UTIs and vitamin D deficiency supports the possible use of cholecalciferol as an adjuvant to basic UTI therapy. Aim. To analyze the vitamin D status in children with UTI compared to healthy ones. Materials and methods. The study included 75 children from 1 month to 18 years with UTIs of various localization treated in a healthcare institution in Stavropol. The mean age of the study patients was 6.0±0.3 years. Vitamin D status was based on serum calcidiol [25(OH)D3] level. Results. The vitamin D level is statistically significantly higher in children of the control group than in patients with UTI: 36.42 ng/mL [24.92–46.37] vs 24.13 ng/mL [13.75–36.42], respectively (p=0.003). There were no patients with severe vitamin deficiency in the control group, while in the UTI group, it occurred in 20.0% of patients. The vitamin D level was less than 20 ng/mL in 31 (41.3%) children with UTI and only 2 (6.6%) in the control group (p=0.001). Normal vitamin status was found in only 38.7% of patients with UTI compared to 66.7% of healthy children (p0.01). The lowest level was found in patients with acute cystitis – 19.7 ng/mL [9.8–19.7], and the highest in patients with acute pyelonephritis – 31.9 ng/mL [14.3–36.4]. Conclusion. Based on the study results, it can be concluded that vitamin D deficiency may be one of the risk factors for developing UTIs in children. Further studies involving more patients are needed.
- 2 December 2023
- Published by Consilium Medicum in Pediatrics. Consilium Medicum
- No. 2,p. 193-197
Open AccessVitamin D supplementation in children with urinary tract infection
Urinary tract infections (UTIs) are one of the most common bacterial infections in the global population. Vitamin D deficiency is also an urgent and common problem, and the high incidence of hypovitaminosis does not depend on age, sex, nationality, and geographical location. Along with the so-called "classical" effects of cholecalciferol, no less significant non-calcemic functions of cholecalciferol have been actively studied over the past two decades, particularly its effect on inflammation and its role in anti-infectious immunity. More and more data on the relationship between UTIs and vitamin D deficiency supports the possible use of cholecalciferol as an adjuvant to basic UTI therapy. Aim. To analyze the vitamin D status in children with UTI compared to healthy ones. Materials and methods. The study included 75 children from 1 month to 18 years with UTIs of various localization treated in a healthcare institution in Stavropol. The mean age of the study patients was 6.0±0.3 years. Vitamin D status was based on serum calcidiol [25(OH)D3] level. Results. The vitamin D level is statistically significantly higher in children of the control group than in patients with UTI: 36.42 ng/mL [24.92–46.37] vs 24.13 ng/mL [13.75–36.42], respectively (p=0.003). There were no patients with severe vitamin deficiency in the control group, while in the UTI group, it occurred in 20.0% of patients. The vitamin D level was less than 20 ng/mL in 31 (41.3%) children with UTI and only 2 (6.6%) in the control group (p=0.001). Normal vitamin status was found in only 38.7% of patients with UTI compared to 66.7% of healthy children (p0.01). The lowest level was found in patients with acute cystitis – 19.7 ng/mL [9.8–19.7], and the highest in patients with acute pyelonephritis – 31.9 ng/mL [14.3–36.4]. Conclusion. Based on the study results, it can be concluded that vitamin D deficiency may be one of the risk factors for developing UTIs in children. Further studies involving more patients are needed.
- Open Access
- 27 July 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 171-181
Bone fractures in children with celiac disease: analysis of clinical and anthropometric measurements and bone metabolism markers
Introduction. Abnormal bone remodelling process is one of the clinical manifestations of celiac disease, which increases the risk of developing osteopenia conditions, including bone fractures. The median age for the first fracture is similar in celiac disease and in the general population, but the incidence is higher in patients with celiac disease.Aim. To compare clinical and anamnestic characteristics, anthropometric measurements and laboratory test results in celiac children and adolescents with and without bone fractures.Materials and methods. A total of 151 children aged 1-17 years were included in the study. Patients were divided into two groups: those who had fractures in their lifetime - 21 (13.9%) children and those who had no fractures - 130 (86.1%) children. Results. The frequency of fractures among the patients included in the study was 13.9%, while among children with vitamin D deficiency fractures were reported 2.7 times more often than among children with its optimal level (p = 0.019).Vitamin D deficiency was detected in 20 (95.2%) children with fractures, and levels of 30 ng/ml or higher were found in 1 (4.8%) child. In the group of patients without fractures, the 25(OH)D optimal level was observed in 43 (33.1%) cases.It was found that patients with fractures had a significantly lower osteocalcin level than children without fractures - 26.9 (15.6; 32.9) ng/ml (p < 0.001), and children with fractures had C-terminal telopeptide level 1.9 times higher than the group of children without fractures (p = 0.01). The median PTH concentration in children with fractures was 34.6 (19.6; 54.7) pg/ml, whereas in children without fractures it was 24.2 (17.1; 39.5) pg/ml (p = 0.1).Conclusion. Due to elevated PTH level and severe vitamin D deficiency, a predominance of osteoresorption over osteosynthesis was observed in children with celiac disease and fractures of tubular bones. It is important to maintain a 25(OH)D optimal level and monitor biochemical markers of bone metabolism in patients with celiac disease to assess the processes of bone formation and resorption.
- 27 July 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 12,p. 171-181
Open AccessBone fractures in children with celiac disease: analysis of clinical and anthropometric measurements and bone metabolism markers
Introduction. Abnormal bone remodelling process is one of the clinical manifestations of celiac disease, which increases the risk of developing osteopenia conditions, including bone fractures. The median age for the first fracture is similar in celiac disease and in the general population, but the incidence is higher in patients with celiac disease.Aim. To compare clinical and anamnestic characteristics, anthropometric measurements and laboratory test results in celiac children and adolescents with and without bone fractures.Materials and methods. A total of 151 children aged 1-17 years were included in the study. Patients were divided into two groups: those who had fractures in their lifetime - 21 (13.9%) children and those who had no fractures - 130 (86.1%) children. Results. The frequency of fractures among the patients included in the study was 13.9%, while among children with vitamin D deficiency fractures were reported 2.7 times more often than among children with its optimal level (p = 0.019).Vitamin D deficiency was detected in 20 (95.2%) children with fractures, and levels of 30 ng/ml or higher were found in 1 (4.8%) child. In the group of patients without fractures, the 25(OH)D optimal level was observed in 43 (33.1%) cases.It was found that patients with fractures had a significantly lower osteocalcin level than children without fractures - 26.9 (15.6; 32.9) ng/ml (p < 0.001), and children with fractures had C-terminal telopeptide level 1.9 times higher than the group of children without fractures (p = 0.01). The median PTH concentration in children with fractures was 34.6 (19.6; 54.7) pg/ml, whereas in children without fractures it was 24.2 (17.1; 39.5) pg/ml (p = 0.1).Conclusion. Due to elevated PTH level and severe vitamin D deficiency, a predominance of osteoresorption over osteosynthesis was observed in children with celiac disease and fractures of tubular bones. It is important to maintain a 25(OH)D optimal level and monitor biochemical markers of bone metabolism in patients with celiac disease to assess the processes of bone formation and resorption.
- Open Access
- 30 March 2023
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 95 (2) , 158-163
Liver damage in children and adolescents with newly diagnosed celiac disease: clinical and anamnestic, serological and morphological patterns
Hypertransaminasemia is a common extra-intestinal manifestation of celiac disease. Aim. To analyze the frequency of hypertransaminasemia, clinical and anamnestic, serological and morphological picture in children in the active period of celiac disease. Materials and methods. The study included 272 children with celiac disease aged from 8 months to 17 years. The patients were divided into two groups: the first children with hypertransaminasemia, the second without hypertransaminasemia. Results. Hypertransaminasemia was detected in 55.9% of children with celiac disease. The age of manifestation of the disease in the first group was 1.0 [0.5; 2.0] years, in the second group 1.9 [0.5; 4.0] years (p=0.0004). Children of the first group were diagnosed at 2.5 [1.7; 4.9] years, the second group at 4.9 [3.0; 10.8] years (p0.001). The duration of the latency period in children of the first and second groups was 1.4 [0.6; 3.1] years and 2.4 [0.9; 4.3] years, respectively (p=0.002). The average values of IgA anti-tTG antibodies in children of the analyzed groups did not differ, and the indicators of IgG anti-tTG antibodies in the first group were 1.6 (p=0.04) times higher. The level of EMA in children with hypertransaminasemia was 2 times higher than in children without hypertransaminasemia. Conclusion. Hypertransaminasemia is more often detected in young children with early manifestation of the disease, increases with the deepening of atrophy in the mucous membrane of the small intestine. Higher titers of celiac-specific antibodies were detected in children with hypertransaminasemia.
- 30 March 2023
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 95 (2) , 158-163
Open AccessLiver damage in children and adolescents with newly diagnosed celiac disease: clinical and anamnestic, serological and morphological patterns
Hypertransaminasemia is a common extra-intestinal manifestation of celiac disease. Aim. To analyze the frequency of hypertransaminasemia, clinical and anamnestic, serological and morphological picture in children in the active period of celiac disease. Materials and methods. The study included 272 children with celiac disease aged from 8 months to 17 years. The patients were divided into two groups: the first children with hypertransaminasemia, the second without hypertransaminasemia. Results. Hypertransaminasemia was detected in 55.9% of children with celiac disease. The age of manifestation of the disease in the first group was 1.0 [0.5; 2.0] years, in the second group 1.9 [0.5; 4.0] years (p=0.0004). Children of the first group were diagnosed at 2.5 [1.7; 4.9] years, the second group at 4.9 [3.0; 10.8] years (p0.001). The duration of the latency period in children of the first and second groups was 1.4 [0.6; 3.1] years and 2.4 [0.9; 4.3] years, respectively (p=0.002). The average values of IgA anti-tTG antibodies in children of the analyzed groups did not differ, and the indicators of IgG anti-tTG antibodies in the first group were 1.6 (p=0.04) times higher. The level of EMA in children with hypertransaminasemia was 2 times higher than in children without hypertransaminasemia. Conclusion. Hypertransaminasemia is more often detected in young children with early manifestation of the disease, increases with the deepening of atrophy in the mucous membrane of the small intestine. Higher titers of celiac-specific antibodies were detected in children with hypertransaminasemia.